Northland Capmk Has Negative Outlook of Transcat Q1 Earnings

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Northland Capmk decreased their Q1 2026 earnings per share estimates for Transcat in a report released on Wednesday, June 4th. Northland Capmk analyst E. Jackson now anticipates that the scientific and technical instruments company will post earnings per share of $0.42 for the quarter, down from their prior estimate of $0.50. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat's Q2 2026 earnings at $0.53 EPS, Q3 2026 earnings at $0.43 EPS and Q4 2026 earnings at $0.62 EPS.

A number of other equities research analysts have also weighed in on TRNS. HC Wainwright restated a "buy" rating and set a $116.00 price objective (up previously from $106.00) on shares of Transcat in a research note on Wednesday, May 21st. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Transcat currently has a consensus rating of "Hold" and a consensus target price of $114.00.

Transcat Stock Down 1.7%

NASDAQ TRNS traded down $1.30 during mid-day trading on Friday, reaching $76.68. 119,793 shares of the company's stock traded hands, compared to its average volume of 84,666. Transcat has a 1-year low of $67.56 and a 1-year high of $147.12. The company has a fifty day simple moving average of $82.20 and a 200-day simple moving average of $88.07. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The company has a market cap of $714.50 million, a price-to-earnings ratio of 41.45 and a beta of 0.75.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company had revenue of $77.13 million during the quarter, compared to analyst estimates of $76.40 million. The company's quarterly revenue was up 8.8% compared to the same quarter last year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Jones Financial Companies Lllp grew its position in shares of Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after acquiring an additional 309 shares in the last quarter. Quantbot Technologies LP acquired a new position in shares of Transcat in the 1st quarter worth approximately $76,000. State of Wyoming acquired a new position in shares of Transcat in the 1st quarter worth approximately $95,000. Aquatic Capital Management LLC grew its position in shares of Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,052 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Transcat by 10,137.5% in the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after acquiring an additional 1,622 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.